Dear Editor,
Ever since the initial discovery and characterization of S-adenosyl-l-methionine (SAM)1, the ATP-activated form of methionine, SAM has become the second most commonly used enzyme cofactor after ATP. A wide variety of macromolecules, including DNA, RNA, proteins, polysaccharides, lipids, and a range of small molecules are subject to methylation by highly specific SAM-dependent methyltransferases (MTases) acting on a particular target atom. Examples of methylation targets include nucleic acids (cytosine-C5, cytosine-N4 and adenine-N6), protein residues (arginine-N, lysine-N, glutamine-N and histidine-N), and small molecules (catechol-O, histamine-N, glycine-N, and thiopurine-S).
Early sequence alignments of known SAM-dependent MTases identified a set of conserved sequence motifs among DNA cytosine-C5 MTases, DNA adenine-N6 and cytosine-N4 MTases, and protein or small molecule MTases2. In essence, the two most conserved sequence motifs reflect the common functions of the MTases: motif I (FxGxG) for binding of the methyl donor SAM and motif IV for catalysis. The residues of motif IV conform in accordance with the target atom, for instance, the PC motif (proline-cysteine) is responsible for ring carbon-C5 methylation of cytosine, whereas the (D/N)PP(Y/F/W) motif for exocyclic amino methylation of adenine and cytosine. However, the apparent sequence and structural similarity do not reveal with certainty whether an enzyme acts on a particular substrate (DNA, RNA or protein). Examples include mammalian DNMT2, which shares sequence and structural similarity with DNA cytosine-C5 MTases3, but is a tRNA cytosine-C5 MTase;4 and Escherichia coli (E. coli) HemK, which was thought to be a DNA amino MTase5, yet is a protein glutamine MTase6,7. The conservation in an enzyme’s sequence and structure merely reflects the conserved nature of catalyzing the methyl transfer onto cytosine-C5 (of DNA and RNA) or amino-group (of adenine and glutamine).
Recently, mammalian HemK2 (NCBI Reference Sequence NP_037372.4) has been documented to be a DNA adenine-N6 MTase8 (renamed as N6AMT1) and a histone H4 lysine-12 MTase9 (renamed as KMT9), in addition to its known activity of glutamine methylation of eukaryotic release factor eRF110. The common feature of the three potential substrates is the amino group (NH2) of glutamine, adenine, and lysine (Fig. 1a). It is rare to have a MTase (or any enzyme per se) capable of acting on both oligonucleotides and protein (and on two different amino acids). Because previous studies8,9 did not compare directly the three potential substrates, here we analyze the in vitro activities of HemK2 on the three substrates side-by-side. HemK2 forms a heterodimeric complex with Trm11210 (named after tRNA methylation protein), and we purified recombinant human HemK2-Trm112 heterodimer expressed in E. coli (Fig. 1b). Sequence of one of the characterized DNA substrates (GAGTC) of HemK28 overlaps with the recognition sequences (GAnTC) of a known bacterial DNA adenine MTase, Caulobacter crescentus cell cycle-regulated MTase11, we thus included CcrM as a positive control. In addition, we included E. coli Dam (DNA adenine MTase) on GATC for comparison12. Both bacterial enzymes were purified in house (Fig. 1b).
We designed five short DNA double-stranded oligos (#1 to #5): #1 contains no-adenine and was used as a negative control, #2, #3 and #4 oligos are thought to be substrates of HemK28, #4 contains the CcrM recognition sequence GAnTC and #5 contains the E. coli Dam recognition sequence GATC (Fig. 1c—the letters T and B designate the top and the bottom strand respectively). Under the conditions where both CcrM and Dam completed reactions on their respective substrates (CcrM on oligo #4 and Dam on oligo #5), we observed no activities of HemK2-Trm112 on the five oligos examined (either double or single stranded) (Fig. 1d–f). However, we did observe activity of HemK2-Trm112 on peptide derived from eRF1 (residues 179–193), much-reduced activity on histone H4 (residues 1–20), and no activity on histone H3 peptide (residues 1–15) at the condition of pH 8 (Fig. 1g). Under the same condition of pH 8, mass spectrometry analysis of peptide substrates confirmed that glutamine-containing eRF1 peptides were fully methylated, whereas H4 peptides had residual methylated species and no methylation of H3 peptides (Fig. 1h).
Most (if not all) SAM-dependent MTases use the classic SN2 reaction mechanism, which requires the target nitrogen be in a deprotonated state. Under the condition (pH 8.0) that HemK2-Trm112 demonstrated strong activity for the glutamine-containing peptide, we observed minor activity on the lysine-containing H4 peptide (Fig. 1i). We reasoned that higher pH conditions might enhance methylation of lysine substrate (with typical pKa value of ~10), as was shown for other biochemically characterized protein (histone) lysine MTases to have optimal in vitro activity at approximately pH 1013. After adjusting the pH to 10.5, the activity of HemK2-Trm112 is significantly increased on H4 peptide (Fig. 1i). An investigation employing peptide array libraries showed that HemK2 methylation activity on eRF1 peptide requires a glycine immediately before and an arginine positioned four-residues after the target glutamine14. H4 K12 meets this requirement with glycine (G11) and a positively charged lysine (K16) in the place of the corresponding arginine of eRF1 (see sequences shown in Fig. 1h). The short H3 peptide (residues 1–15) used in the assay does contain one glutamine and three lysine residues but is not a methylation substrate of HemK2. Finally, HemK2-Trm112 complex structure (PDB 6H1E9) illustrates a negatively charged substrate interface (Fig. 1j), ideal for positively charged peptides such as eRF1 and histone H4, but unsuitable for a negatively charged DNA substrate. We note that the activity on glutamine-containing eRF1 peptide is significantly reduced at the high pH (Fig. 1i), suggesting that high pH is not optimal for catalysis and/or stability of HemK2-Trm112 complex. For the lysine-containing H4 peptide, however, deprotonation of lysine by high pH is preferred for methylation to occur, but only to a much-reduced level as compared with that of glutamine methylation at pH 8.
In sum, using two established MTase assays in vitro, following either incorporation of tritium from 3H-SAM into a substrate or formation of byproduct SAH in a bioluminescence assay, we show that human HemK2-Trm112 heterodimer is only active on protein glutamine and lysine, but not active on DNA. In light of current interests on N6-methyladenine in eukaryotic genomic DNA, our study resolves one controversy in the field. Additional data will be required to address the dual specificity of HemK2 on protein glutamine and lysine—a unique property for a MTase working on two different substrates with different target residues, one is located in the cytoplasm (eRF1, glutamine) and the other in nucleus (histone H4, lysine).
Finally, we want to clearly highlight the differences between our studies presented here and that of Xiao et al.8. (1) We used recombinant HemK2-Trm112 complex expressed in E. coli and purified using a four-column chromatography, whereas Xiao et al. used N6AMT1-Flag plasmid transfected into HEK293T cells and protein purified according to the kit instructions, presumably one-step affinity purification. (2) We used purified HemK2-Trm112 complex (Fig. 1b), whereas there was no mention whether the protein preparation used by Xiao et al. contains Trm112. In a separate study, partially purified Flag-N6AMT1 from overexpressing HEK293T cells appeared to contain a ~15-kDa protein that might be co-purified endogenous Trm112, and this protein preparation did not methylate DNA oligonucleotides in vitro as shown by N6mA specific antibody (see Fig. S4 of Xie et al.15). (3) Our fluorography assays on DNA (Fig. 1f) were conducted with [E] = 2 μM, [S] = 10 μM, and [3H-SAM] = 10 μM, whereas Xiao et al. used 25 µl reaction system containing [E] = 0.8 μg (~0.8 μM), [SDNA] = 250 pmol (=10 µM), [3H-SAM] = 55 μM (which is puzzling as that is the concentration of the PerkinElmer NET155V [3H-SAM] stock). Both reactions were carried out at 25 °C overnight under similar buffer and salt conditions.
References
Cantoni, G. L. The nature of the active methyl donor formed enzymatically from l-methionine and adenosinetriphosphate. J. Am. Chem. Soc. 74, 2942–2943 (1952).
Malone, T., Blumenthal, R. M. & Cheng, X. Structure-guided analysis reveals nine sequence motifs conserved among DNA amino-methyltransferases, and suggests a catalytic mechanism for these enzymes. J. Mol. Biol. 253, 618–632 (1995).
Dong, A. et al. Structure of human DNMT2, an enigmatic DNA methyltransferase homolog that displays denaturant-resistant binding to DNA. Nucleic Acids Res. 29, 439–448 (2001).
Goll, M. G. et al. Methylation of tRNAAsp by the DNA methyltransferase homolog Dnmt2. Science 311, 395–398 (2006).
Bujnicki, J. M. & Radlinska, M. Is the HemK family of putative S-adenosylmethionine-dependent methyltransferases a “missing” zeta subfamily of adenine methyltransferases? A hypothesis. IUBMB Life 48, 247–249 (1999).
Nakahigashi, K. et al. HemK, a class of protein methyl transferase with similarity to DNA methyl transferases, methylates polypeptide chain release factors, and hemK knockout induces defects in translational termination. Proc. Natl Acad. Sci. USA 99, 1473–1478 (2002).
Heurgue-Hamard, V., Champ, S., Engstrom, A., Ehrenberg, M. & Buckingham, R. H. The hemK gene in Escherichia coli encodes the N(5)-glutamine methyltransferase that modifies peptide release factors. EMBO J. 21, 769–778 (2002).
Xiao, C. L. et al. N(6)-methyladenine DNA modification in the human genome. Mol. Cell 71, 306–318 (2018).
Metzger, E. et al. KMT9 monomethylates histone H4 lysine 12 and controls proliferation of prostate cancer cells. Nat. Struct. Mol. Biol. 26, 361–371 (2019).
Figaro, S., Scrima, N., Buckingham, R. H. & Heurgue-Hamard, V. HemK2 protein, encoded on human chromosome 21, methylates translation termination factor eRF1. FEBS Lett. 582, 2352–2356 (2008).
Zweiger, G., Marczynski, G. & Shapiro, L. A Caulobacter DNA methyltransferase that functions only in the predivisional cell. J. Mol. Biol. 235, 472–485 (1994).
Horton, J. R., Liebert, K., Hattman, S., Jeltsch, A. & Cheng, X. Transition from nonspecific to specific DNA interactions along the substrate-recognition pathway of dam methyltransferase. Cell 121, 349–361 (2005).
Zhang, X. et al. Structure of the Neurospora SET domain protein DIM-5, a histone H3 lysine methyltransferase. Cell 111, 117–127 (2002).
Kusevic, D., Kudithipudi, S. & Jeltsch, A. Substrate specificity of the HEMK2 protein glutamine methyltransferase and identification of novel substrates. J. Biol. Chem. 291, 6124–6133 (2016).
Xie, Q. et al. N(6)-methyladenine DNA Modification in Glioblastoma. Cell 175, 1228–1243 (2018).
Acknowledgements
This work was supported by grants from NIH (GM049245) and CPRIT (RR160029). The Proteomics and Metabolomics Facilities were supported in part by CPRIT (RP130397) and NIH (1S10OD012304 and P30CA016672). We thank Dr. John R. Horton for providing purified E. coli Dam.
Author information
Authors and Affiliations
Contributions
C.B.W. performed protein purification and enzymatic assays. D.Y. made Trm112 construct. X.Z. and X.C. organized and designed the scope of the study. All were involved in analyzing data and preparing the manuscript.
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Woodcock, C.B., Yu, D., Zhang, X. et al. Human HemK2/KMT9/N6AMT1 is an active protein methyltransferase, but does not act on DNA in vitro, in the presence of Trm112. Cell Discov 5, 50 (2019). https://doi.org/10.1038/s41421-019-0119-5
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41421-019-0119-5
This article is cited by
-
Means, mechanisms and consequences of adenine methylation in DNA
Nature Reviews Genetics (2022)
-
Bacterial N4-methylcytosine as an epigenetic mark in eukaryotic DNA
Nature Communications (2022)
-
Mammalian HEMK1 methylates glutamine residue of the GGQ motif of mitochondrial release factors
Scientific Reports (2022)
-
Epigenetics and beyond: targeting writers of protein lysine methylation to treat disease
Nature Reviews Drug Discovery (2021)